Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Feb 1;109(2):182-190.
doi: 10.1093/bjs/znab411.

Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis

Affiliations
Meta-Analysis

Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis

Kai Sheng Saw et al. Br J Surg. .

Erratum in

Abstract

Background: This review evaluated the utility of single quantitative faecal immunochemical test (FIT) as a triaging tool for patients with symptoms of possible colorectal cancer, the effect of symptoms on FIT accuracy, and the impact of triaging incorporating FIT on service provision.

Methods: Five databases were searched. Meta-analyses of the extracted FIT sensitivities and specificities for detection of colorectal cancer at reported f-Hb thresholds were performed. Secondary outcomes included sensitivity and specificity of FIT for advanced colorectal neoplasia and serious bowel disease. Subgroup analysis by FIT brand and symptoms was undertaken.

Results: Fifteen prospective cohort studies, including 28 832 symptomatic patients were included. At the most commonly reported f-Hb positivity threshold of ≥ 10 µg Hb/g faeces (n=13), the summary sensitivity was 88.7% (95% c.i. 85.2 to 91.4) and the specificity was 80.5% (95% c.i. 75.3 to 84.8) for colorectal cancer. At lower limits of detection of ≥ 2 µg Hb/g faeces, the summary sensitivity was 96.8% (95% c.i. 91.0 to 98.9) and the specificity was 65.6% (95% c.i. 59.0 to 71.6). At the upper f-Hb positivity thresholds of ≥ 100 µg Hb/g faeces and ≥ 150 µg Hb/g faeces, summary sensitivities were 68.1% (95% c.i. 59.2 to 75.9) and 66.3% (95% c.i. 52.2 to 78.0), with specificities of 93.4% (95% c.i. 91.3 to 95.1) and 95.1% (95% c.i. 93.6 to 96.3) respectively. FIT sensitivity was comparable between different assay brands. FIT sensitivity may be higher in patients reporting rectal bleeding.

Conclusion: Single quantitative FIT at lower f-Hb positivity thresholds can adequately exclude colorectal cancer in symptomatic patients and provides a data-based approach to prioritization of colonoscopy resources.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
PRISMA diagram showing selection of articles for review
Fig. 2
Fig. 2
Summary receiver operating characteristic curves for faecal immunochemical test at various faecal haemoglobin positivity thresholds for detection of colorectal cancer. Solid lines represent summary receiver operator characteristic curve. Full coloured points on solid lines represents the summary estimate point. Area within Dashed lines represent the 95% confidence region. Washed out/Lighter coloured points represent individual study cohorts Size of washed out/Lighter coloured points is proportional to number of participants of each study (i.e. larger symbol means bigger number of participant/larger study)

References

    1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–E386. - PubMed
    1. Wong MCS, Huang J, Lok V, Wang J, Fung F, Ding H et al. Differences in incidence and mortality trends of colorectal cancer worldwide based on sex, age, and anatomic location. Clin Gastroenterol Hepatol 2021;19:955–966.e61. - PubMed
    1. Vega P, Valentin F, Cubiella J. Colorectal cancer diagnosis: pitfalls and opportunities. World J Gastrointest Oncol 2015;7:422–433. - PMC - PubMed
    1. Westwood M, Corro Ramos I, Lang S, Luyendijk M, Zaim R, Stirk L et al. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis. Health Technol Assess 2017;21:1–234. - PMC - PubMed
    1. Mowat C, Digby J, Strachan JA, McCann RK, Carey FA, Fraser CG et al. Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care. Ann Clin Biochem 2021;58:211–219. - PMC - PubMed

Publication types